Fresenius Medical Care AG FMS
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 4.76% | -8.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.76% | -8.56% | |||
| Cost of Revenue | 2.82% | -6.28% | |||
| Gross Profit | 10.41% | -14.61% | |||
| SG&A Expenses | -2.31% | -4.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -36.20% | 162.34% | |||
| Total Operating Expenses | 1.76% | -4.90% | |||
| Operating Income | 38.60% | -36.24% | |||
| Income Before Tax | 83.47% | -58.98% | |||
| Income Tax Expenses | 108.87% | -59.63% | |||
| Earnings from Continuing Operations | 76.88% | -58.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -57.41% | 36.65% | |||
| Net Income | 84.71% | -63.88% | |||
| EBIT | 38.60% | -36.24% | |||
| EBITDA | 20.11% | -6.24% | |||
| EPS Basic | 89.39% | -62.48% | |||
| Normalized Basic EPS | 10.08% | -35.94% | |||
| EPS Diluted | 88.57% | -62.48% | |||
| Normalized Diluted EPS | 10.08% | -35.94% | |||
| Average Basic Shares Outstanding | -2.47% | -3.73% | |||
| Average Diluted Shares Outstanding | -2.47% | -3.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||